Medical Devices

Zepto Life Technology's FDA Breakthrough status for a fungal test isn't just a win for patients; it's a strategic move in liquid biopsy's new frontier.

As autonomous AI enters healthcare, Datavant joins a key consortium to build the safety guardrails, ensuring patient trust and data integrity remain paramount.

New long-term data for UPLIZNA and TAVNEOS show sustained disease control and reduced steroid use, offering a tangible difference for rare disease patients.

As Alexandria grapples with a documented mental health crisis, a new clinic introduces advanced TMS and ketamine therapies to a region burdened by long waits.

Insulet's latest Omnipod 5 enhancements are more than a software update; they're a strategic move in the diabetes tech race. Here's what it means.

Perspective Therapeutics is testing a potent alpha-particle therapy for meningioma, the most common brain tumor, offering a new option where surgery fails.

MiniMed and Abbott are partnering on a dual glucose-ketone sensor, a move that could shift diabetes care from crisis management to proactive DKA prevention.

Freshly independent, MiniMed reports record sales and a robust product pipeline, signaling a focused strategy to dominate the competitive diabetes tech market.

Precision Cardiovascular adds serial entrepreneur Brian Fahey to its board, signaling a push to commercialize its implantable SAW sensor and AI platform.

EZContacts' new 'top retailer' award highlights the online eyewear boom. But the real story is the underlying system reshaping a regulated, high-friction industry.

As the world grapples with drug-resistant bacteria, an Israeli biotech is testing a novel drug that physically destroys pathogens. Can it turn the tide?

A new lawsuit over atmospheric plasma technology could disrupt supply chains for AI chips and medical devices, highlighting fierce IP battles in high-tech.

A new report shows California's self-insured employers face a puzzling trend: workers' comp claims are at a 5-year low, yet costs are surging. Why?

With CE Mark approval for its SOUND REACH Swift, Genesis MedTech brings a 'plug-and-play' ultrasonic shear to Europe, promising to simplify complex open surgeries.

A breakthrough in industrial packaging: a new VCI film that is both 100% recyclable and biodegrades in landfills, offering a dual solution to plastic waste.

A call for research on vaccine side effects exposes a deeper crisis: the collapse of public trust in science. Can rigorous data heal a polarized nation?

Bluejay Diagnostics secures critical funding to advance its rapid sepsis test, extending its cash runway but raising questions about shareholder dilution.

Mindray's new Hepatus-Series goes beyond a simple product launch, integrating AI-driven elastography to transform GI diagnostics and challenging market norms.

Nephrodite's implantable dialysis system just entered a key FDA program, signaling a major shift in treating kidney failure. Is freedom from the dialysis chair finally in sight?

A burgeoning market for cervical dystonia is set for disruption. A pipeline of novel therapies, including oral options, promises to address unmet patient needs.